Rick Wise
Stock Analyst at Stifel
(4.50)
# 302
Out of 4,711 analysts
220
Total ratings
66.85%
Success rate
12.93%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: Buy | $525 → $610 | $524.43 | +16.32% | 17 | Dec 5, 2024 | |
| EW Edwards Lifesciences | Maintains: Hold | $70 → $75 | $74.81 | +0.25% | 22 | Dec 5, 2024 | |
| MASI Masimo | Reiterates: Buy | $170 → $190 | $169.52 | +12.08% | 14 | Nov 22, 2024 | |
| BAX Baxter International | Maintains: Buy | $46 → $38 | $29.50 | +28.81% | 8 | Nov 11, 2024 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $7 → $8 | $6.96 | +14.94% | 8 | Nov 6, 2024 | |
| LUNG Pulmonx | Maintains: Buy | $17 → $16 | $6.15 | +160.16% | 4 | Oct 31, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $85 → $100 | $88.95 | +12.42% | 15 | Oct 18, 2024 | |
| SOLV Solventum | Initiates: Buy | $82 | $66.83 | +22.70% | 1 | Oct 8, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $100 → $102 | $78.91 | +29.26% | 2 | Sep 30, 2024 | |
| AORT Artivion | Maintains: Buy | $28 → $30 | $28.48 | +5.34% | 5 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $85 → $87 | $81.03 | +7.37% | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $76 | $68.63 | +10.74% | 9 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $375 → $365 | $364.60 | +0.11% | 15 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $26 | $30.72 | -15.36% | 12 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $280 | $227.68 | +22.98% | 7 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $72 | $47.59 | +51.29% | 5 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $7.25 | +65.52% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $92.12 | -18.58% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $34 | $22.38 | +51.92% | 5 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $35.91 | -33.17% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $6 | $1.21 | +395.87% | 4 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $16.08 | +55.47% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 | $107.12 | +54.03% | 13 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $125 | $114.23 | +9.43% | 18 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $68.25 | +64.10% | 5 | Oct 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $155 | $144.47 | +7.29% | 5 | Apr 15, 2020 |
Intuitive Surgical
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $524.43
Upside: +16.32%
Edwards Lifesciences
Dec 5, 2024
Maintains: Hold
Price Target: $70 → $75
Current: $74.81
Upside: +0.25%
Masimo
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $169.52
Upside: +12.08%
Baxter International
Nov 11, 2024
Maintains: Buy
Price Target: $46 → $38
Current: $29.50
Upside: +28.81%
Treace Medical Concepts
Nov 6, 2024
Maintains: Hold
Price Target: $7 → $8
Current: $6.96
Upside: +14.94%
Pulmonx
Oct 31, 2024
Maintains: Buy
Price Target: $17 → $16
Current: $6.15
Upside: +160.16%
Boston Scientific
Oct 18, 2024
Maintains: Buy
Price Target: $85 → $100
Current: $88.95
Upside: +12.42%
Solventum
Oct 8, 2024
Initiates: Buy
Price Target: $82
Current: $66.83
Upside: +22.70%
GE HealthCare Technologies
Sep 30, 2024
Maintains: Buy
Price Target: $100 → $102
Current: $78.91
Upside: +29.26%
Artivion
Sep 13, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $28.48
Upside: +5.34%
Aug 21, 2024
Maintains: Hold
Price Target: $85 → $87
Current: $81.03
Upside: +7.37%
Aug 1, 2024
Maintains: Buy
Price Target: $88 → $76
Current: $68.63
Upside: +10.74%
Jul 31, 2024
Maintains: Buy
Price Target: $375 → $365
Current: $364.60
Upside: +0.11%
Jul 31, 2024
Maintains: Buy
Price Target: $30 → $26
Current: $30.72
Upside: -15.36%
Jul 26, 2024
Maintains: Buy
Price Target: $270 → $280
Current: $227.68
Upside: +22.98%
Jul 25, 2024
Maintains: Buy
Price Target: $70 → $72
Current: $47.59
Upside: +51.29%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $7.25
Upside: +65.52%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $92.12
Upside: -18.58%
Mar 7, 2024
Maintains: Buy
Price Target: $32 → $34
Current: $22.38
Upside: +51.92%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $35.91
Upside: -33.17%
Oct 13, 2023
Maintains: Buy
Price Target: $26 → $6
Current: $1.21
Upside: +395.87%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $16.08
Upside: +55.47%
Jun 2, 2023
Maintains: Buy
Price Target: $165
Current: $107.12
Upside: +54.03%
Jan 26, 2023
Maintains: Buy
Price Target: $110 → $125
Current: $114.23
Upside: +9.43%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $68.25
Upside: +64.10%
Apr 15, 2020
Maintains: Hold
Price Target: $140 → $155
Current: $144.47
Upside: +7.29%